Moomoo AI 已提取核心信息
Richard A. Colvin, Chief Medical Officer of bluebird bio, Inc., completed a sale of 6,770 shares of common stock on March 1, 2024. The transaction was carried out in the open market with the shares sold at a price of $1.5276 each, resulting in a total sale value of $10,341.85. Following the sale, Colvin's direct holdings in the company amount to 118,368 shares of common stock.
Richard A. Colvin, Chief Medical Officer of bluebird bio, Inc., completed a sale of 6,770 shares of common stock on March 1, 2024. The transaction was carried out in the open market with the shares sold at a price of $1.5276 each, resulting in a total sale value of $10,341.85. Following the sale, Colvin's direct holdings in the company amount to 118,368 shares of common stock.
蓝鸟生物公司首席医学官理查德·科尔文于2024年3月1日完成了6,770股普通股的出售。该交易在公开市场上进行，股票以每股1.5276美元的价格出售，总销售价值为10,341.85美元。出售后，科尔文在公司的直接持有量为118,368股普通股。
蓝鸟生物公司首席医学官理查德·科尔文于2024年3月1日完成了6,770股普通股的出售。该交易在公开市场上进行，股票以每股1.5276美元的价格出售，总销售价值为10,341.85美元。出售后，科尔文在公司的直接持有量为118,368股普通股。
有用
没用